The probable mechanism responsible for the effectiveness of the therapy is the inhibition of angiogenesis evoked by MSC/IL-12 cells and the increase in the percentage of M1 macrophages and CD8 T lymphocytes in the tumor tissue. The gene discussed is CD8A; the disease is neoplasm.